Volver

IDEXX Laboratories Inc

Ticker: IDXX ISIN: US45168D1046
Añadir al portafolio Análisis de cartera en 2min
Stock Large-cap High beta Trading above 200-day average Near 52-week high
Capitalización
34,63 MM $
P/E
40,82
Forward P/E
37,04
Profit margin
22,53%
Revenue growth QoQ
6,60%
Beta
1,36
554,99 $ 1,82%
Precio a fecha de 2026-08-28 · NASDAQ

Rendimiento por período

Rendimientos acumulados
1 Month -0,68%
6 Months -12,83%
1 Year -14,23%
5 Years -4,18% p.a.-19,21%
10 Years +17,30% p.a.+392,54%
Since inception +19,95% p.a.+9 314,59%
Rendimientos por año
YTD -17,97%
2025 +63,63%
2024 -25,51%
2023 +36,06%
2022 -38,04%
2021 +31,73%

Key stats

Market cap
34,63 MM
P/E
40,82
Beta
1,36
52-week range
398.50 - 583.39
50-day MA
423,43
200-day MA
473,52
Section 1

Business overview

Company profile data from fundamentals.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Sector Healthcare
Industry Diagnostics & Research
Country United States
Exchange NASDAQ
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 59,42%
ROA 22,79%
Profit margin 22,53%
Operating margin 37,46%
PEG ratio 4,41
Revenue/share TTM 46,45
Revenue TTM 3,84 MM
EBITDA 1,30 MM
Gross profit TTM 2,33 MM
Beta 1,36

Valuation

Trailing P/E 40,82
Forward P/E 37,04
P/B 21,19
P/S 9,01
EV/EBITDA 27,93
EV/Revenue 9,10

ESG Scores

Total ESG 29,8
Environment 9,9
Social 14,4
Governance 17,9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 10,73
Quarterly earnings growth 10,70%
Revenue TTM 3,84 MM
Reported quarters 118
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0,00%
Split factor 2:1
Last split date 2015-06-16
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 478,62 $
Analyst rating 3.6429

Ownership & short interest

Shares outstanding 81,88 M
Shares float 80,97 M
Institutional ownership 95,14%
Insider ownership 94,30%
Short ratio 2,57
Short % of float 2,35%

Details

Instrument metadata and source update timestamps.

Symbol IDXX
Name IDEXX Laboratories Inc
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US45168D1046
Country USA
Code + exchange IDXX.NASDAQ
Fundamentals updated 2025-01-16

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.